Table 2 Proportion of patients with no radiographic progression according to mSASSS cut-offs of ≤0, ≤0.5, ≤1.0, and ≤ 2.0

Primary analysis set (BL to Days 31–743)

M: 168 (84%); E: 69 (57%)

M: 60.7%; E: 52.2%

M: 68.5%; E: 62.3%

M: 78.0%; E: 69.6%

M: 82.1%; E: 72.5%

Sensitivity analysis set 1 (BL to Days 640–819)

M: 178 (89%); E: 82 (67%)

M: 61.2%; E: 56.1%

M: 68.0%; E: 63.4%

M: 77.5%

E: 72.0%

M: 81.5%; E: 75.6%

Sensitivity analysis set 2 (All patients, time-adjusted)^a

M: 201 (100%); E: 122 (100%)

M: 59.8%; E: 50.1%

M: 68.5%; E: 62.4%

M: 79.2%; E: 72.1%

M: 84.6%; E: 75.4%